These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35668885)

  • 1. A Conversation on an Effective, Straightforward, Quantitative Approach to the Outpatient Use of Insulin.
    Davidson MB
    Diabetes Spectr; 2022; 35(2):179-189. PubMed ID: 35668885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.
    Philis-Tsimikas A; Charpentier G; Clauson P; Ravn GM; Roberts VL; Thorsteinsson B
    Clin Ther; 2006 Oct; 28(10):1569-81. PubMed ID: 17157113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.
    Yki-Järvinen H; Kauppila M; Kujansuu E; Lahti J; Marjanen T; Niskanen L; Rajala S; Ryysy L; Salo S; Seppälä P
    N Engl J Med; 1992 Nov; 327(20):1426-33. PubMed ID: 1406860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens.
    Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW
    Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
    Murphy NP; Keane SM; Ong KK; Ford-Adams M; Edge JA; Acerini CL; Dunger DB
    Diabetes Care; 2003 Mar; 26(3):799-804. PubMed ID: 12610040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different daily blood glucose control and free insulin levels during treatment with mixtures of soluble and lente or soluble and NPH semisynthetic human insulins.
    Cucinotta D; Di Benedetto A; Gigante A; Di Cesare E; Musolino C; Squadrito G
    Diabete Metab; 1989; 15(4):182-7. PubMed ID: 2680669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children.
    Mimouni M; Koivukangas T; Karp M; Laron Z
    Acta Diabetol Lat; 1979; 16(1):63-6. PubMed ID: 377878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM.
    Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD
    Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique.
    Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A
    Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
    Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB
    Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus.
    Sethi B; Unnikrishnan AG; Ayyar V; Jabbar PK; Ganguly KK; Bhandari S; Rastogi A; Mukherjee R; Sundaram V; Asirvatham AR
    Diabetes Ther; 2022 Aug; 13(8):1409-1481. PubMed ID: 35768707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.
    Buysschaert M; Minette P; Ketelslegers JM; Pairet JV; Vogels M; Lambert AE
    Diabetes Res; 1987 Jan; 4(1):31-3. PubMed ID: 3552364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.